---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-050580"
form_type: "8-K"
ticker: "GERN"
cik: "0000886744"
company_name: "GERON CORP"
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T07:17:26.810034+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Geron's imetelstat MAA for lower-risk MDS validated by EMA for review

## Summary
- MAA for imetelstat in transfusion-dependent anemia with lower-risk MDS validated by EMA.
- Review by CHMP under centralized procedure covering all 27 EU states plus Iceland, Norway, Liechtenstein.
- Expected review period of approximately 14 months.
- Submission made in September 2023; now under regulatory review.

## SEC filing metadata
- accession: 0000950170-23-050580
- form_type: 8-K
- ticker: GERN
- cik: 0000886744
- company_name: GERON CORP
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886744/000095017023050580/0000950170-23-050580-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886744/000095017023050580/gern-20230928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-050580
- JSON: https://secwatch.observer/filing/0000950170-23-050580.json
- Plain text: https://secwatch.observer/filing/0000950170-23-050580.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.